TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
BioStock AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
17,568
|
19,259
|
18,779 |
| Financial expenses |
2
|
10
|
17 |
| Earnings before taxes |
1,358
|
1,739
|
2,597 |
| EBITDA |
1,514
|
1,885
|
2,738 |
| Total assets |
5,023
|
5,906
|
9,206 |
| Current assets |
4,811
|
5,520
|
8,725 |
| Current liabilities |
2,327
|
2,472
|
4,997 |
| Equity capital |
2,450
|
3,192
|
3,982 |
| - share capital |
62
|
61
|
57 |
| Employees (average) |
10
|
0
|
16 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
48.8%
|
54.0%
|
43.3% |
| Turnover per employee | 1,757 | 1,174 | |
| Profit as a percentage of turnover |
7.7%
|
9.0%
|
13.8% |
| Return on assets (ROA) |
27.1%
|
29.6%
|
28.4% |
| Current ratio |
206.7%
|
223.3%
|
174.6% |
| Return on equity (ROE) |
55.4%
|
54.5%
|
65.2% |
| Change turnover |
-2,038
|
-853
|
1,567 |
| Change turnover % |
-10%
|
-4%
|
9% |
| Chg. No. of employees |
10
|
-16
|
4 |
| Chg. No. of employees % |
-100%
|
33% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.